bioRxivSystems BiologyPreprint
Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants
Riaz‐Ali SomjiiD, Jonathan C. BrowniD, Shahid Rowles-KhalidiD, Tukur Baba AbdullahiiD, Dongsheng LuoiD, Natalie BartheliD, Michael MüllederiD, Markus RalseriD, William BarclayiD, Charalampos RallisiD, Efstathios S. GiotisiD
Abstract
SARS-CoV-2 variants differ in transmissibility and immune evasion, but their effects on host-cell metabolism and signalling remain less defined. Using integrated transcriptomic, phosphoproteomic, and amino acid profiling in primary nasal epithelial cells, we compared early and late host responses to pre-Omicron variants (Alpha, Beta), Delta, and Omicron subvariants (BA.1, BA.5). Pre-Omicron strains broadly suppressed antiviral interferon-stimulated gene expression and reprogrammed metabolism by reducing mitochondrial oxidative phosphorylation and {beta}-oxidation. Delta infection was associated with extensive transcriptional and metabolic remodelling, characterised by activation of stress- and growth-related kinases and selective retention of biosynthetic amino acids, consistent with a host response to stress and viral modulation of interferon-associated signalling. In contrast, Omicron infection elicited a more restrained response dominated by cytokine and survival pathways, with limited metabolic activation and interferon suppression. Together, these findings suggest SARS-CoV-2 has progressively evolved toward a strategy that maintains efficient upper-airway replication while minimising epithelial stress and inflammation.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, … Nevan J. Krogan·bioRxiv·Oct 19, 2022
- Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
L. Shalamova, U. Felgenhauer, … F. Weber·bioRxiv·Jan 20, 2022
- Multi-Omic Profiling Identifies Conserved Metabolic Pathways Critical for SARS-CoV-2 Variants Infection
Scotland E. Farley, Jennifer E Kyle, … Fikadu Tafesse·bioRxiv·Jun 2, 2025
- Interferon Resistance of Emerging SARS-CoV-2 Variants
K. Guo, B. S. Barrett, … M. L. Santiago·bioRxiv·Mar 20, 2021
- SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
D. Bojkova, T. Rothenburger, … J. Cinatl·bioRxiv·Jan 20, 2022
- SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses
D. Tandel, V. Sah, … K. H. Harshan·bioRxiv·Feb 22, 2022